Some prostate cancer drugs actually help spread the diseaseAugust 22nd, 2008 - 5:33 pm ICT by ANI
Washington, Aug 22 (ANI): Researchers from the University of Rochester Medical Centre have found that certain prostate cancer drugs can spur some cancer cells to grow.
Hormone therapy, a common treatment for men with advanced prostate cancer, generally keeps the cancer at bay for a year or two, but later fails in patients whose disease has spread.
The team led by Chawnshang Chang, Ph.D., director of the George Whipple Laboratory for Cancer Research at the University of Rochester Medical Center showed that androgen receptor, through which male hormones like testosterone work under certain conditions spurs growth, and at other times inhibits growth- just like the same molecule does to hair in different locations on a man’’s head.
The researchers said that these findings raise the possibility that under some conditions, certain treatments designed to treat prostate cancer could instead remove one of the body’’s natural brakes on the spread of the disease in the body.
The research in the laboratory involved tracking the disease in mice and also analysing human prostate cancer cells in culture.
“When a man receives hormone therapy, initially the treatment works well, and his PSA (prostate specific antigen) level goes down,” said Edward Messing, M.D., a urologist and an author of the paper.
“But inevitably, the PSA will start climbing again, and that is usually the first sign that the treatment is beginning to fail. It’’s a sign that the cancer in the prostate is making a comeback,” he added.
The research team found that blocking the receptor indeed prevents some cells in the prostate from growing, but unexpectedly blocking the receptor can actually spurs other prostate cells to grow.
The androgen receptor in prostate support cells known as stromal cells stimulates growth of cells. After turning off the molecule in stromal cells, growth of cancer cells in the prostate slowed down.
“The effects of the androgen receptor on hair growth in men vary dramatically depending on where in the body the receptor is working,” said Chang.
“When the receptor is very active in the mustache area, more hair grows. When it’’s very active on the top of the skull, toward the front, hair falls out and men become bald. And the hair on the back of the head is insensitive to the receptor. The effects of hormones depend on the location.
“We found that the same is true within the cells of the prostate itself,” he added.
The findings are published online in Proceedings of the National Academy of Sciences. (ANI)
- Molecular receptor in testosterone heals wounds quickly - Jan 05, 2010
- Why men get liver cancer more often than women - May 20, 2010
- Gene fusion is the 'smoking gun' in the development of prostate cancer: Study - May 19, 2010
- Why PSA levels reflect prostate cancer progression - Jan 14, 2011
- Treatment for prostate cancer can be self-defeating - Aug 22, 2008
- Molecule discovery good news for prostate cancer sufferers - Dec 29, 2009
- Receptor behind testosterone activity plays key role in wound healing - Jan 05, 2010
- Australian scientists identify new way to treat prostate cancer - Feb 26, 2010
- Beer may prevent prostate cancer - Dec 09, 2009
- Researchers look at new treatment for prostate cancer - Nov 15, 2010
- Protein that protects against prostate cancer discovered - Feb 01, 2011
- Magnets help fight prostate cancer - Nov 09, 2011
- Male sex hormones that mutate in prostate cancer identified - Nov 15, 2010
- Simple test could save prostate cancer patients from surgery - Feb 09, 2011
- Antibiotic used in meat, dairy industry slows prostate cancer growth - Dec 21, 2010
Tags: cancer drugs, human prostate cancer, male hormones, prostate cancer cells, prostate cells, prostate specific antigen, rochester medical center, stromal cells, support cells, university of rochester medical center